Clinical Trials Browser

Refractory or Relapsed Solid Tumors × darolutamide × 90 days × Clear all

NCT07620041 2026-06-02

QLC5508 in Advanced Solid Tumors:: C-QTc, Pharmacokinetics (PK) Comparisons and Drug-drug Interaction

Phase 1 Not yet recruiting

Other solid neoplasm

Refractory or Relapsed Solid Tumors